[1]
Masood, M. et al. 2023. Adverse Event Profile in Advance Hepatocellular Carcinoma treated with Sorafenib Presenting to CMH Rawalpindi. Pakistan Armed Forces Medical Journal. 73, 4 (Aug. 2023), 1071–1074. DOI:https://doi.org/10.51253/pafmj.v73i4.7889.